CASTRATION-RESISTANT PROSTATE CANCER
Clinical trials for CASTRATION-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CASTRATION-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Two-Drug combo tested as new hope for Tough-to-Treat cancers
Disease control TerminatedThis study tested whether adding an experimental drug called SOT101 to an existing immunotherapy (pembrolizumab) could help control advanced cancers that had stopped responding to other treatments. It involved 166 adults with specific advanced solid tumors, including lung, colore…
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: SOTIO Biotech AG • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Drug combo test halted early for business reasons
Disease control TerminatedThis study aimed to see if combining two drugs, cabozantinib and abiraterone, was safe and effective for men with advanced prostate cancer that had spread to their bones and was no longer responding to standard hormone therapy. Participants were assigned to receive different dose…
Matched conditions: CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE2 • Sponsor: Exelixis • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC